Auxogyn Accepts $20 Million VC Financing


	Subscribe \| Contact Us \|

Friday, February 03, 2012 5:40:00 AM PDT | VentureDeal Staff

Menlo Park, California -- Biotechnology company Auxogyn has announced the close of $20 million in first-round venture capital investment.

Auxogyn has developed a system designed to "assist reproductive specialists in improving the percentage of in vitro fertilization procedures that result in a live birth."

Investors in the round included Kleiner Perkins Caufield & Byers, TPG Biotech and Merck Serono Ventures.

The company will use the financing to continue its clinical study efforts.

Email Page | Print Page

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.